Evidence map›Paper›PMID 42564310›Full record

ArticleComputational and structural biotechnology journal2026

A Physics-Inspired Approach to Improve Oligonucleotide Design and Gene Synthesis.

David Luna-Cerralbo, Ana Serrano, Fadi Hamdan, Juan Martínez-Oliván, Pierpaolo Bruscolini

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

David Luna-CerralboDepartamento de Física Teórica, Facultad de Ciencias, Universidad de Zaragoza, Zaragoza 50009, Spain.ORCID https://orcid.org/0009-0000-3448-1314
Ana SerranoCertest Pharma, Certest Biotec S.L, Polígono Industrial Río Gállego II, Calle J, 1, San Mateo de Gállego 50840, Spain.ORCID https://orcid.org/0000-0002-7057-0418
Fadi HamdanCertest Pharma, Certest Biotec S.L, Polígono Industrial Río Gállego II, Calle J, 1, San Mateo de Gállego 50840, Spain.ORCID https://orcid.org/0009-0004-8974-0482
Juan Martínez-OlivánCertest Pharma, Certest Biotec S.L, Polígono Industrial Río Gállego II, Calle J, 1, San Mateo de Gállego 50840, Spain.ORCID https://orcid.org/0009-0007-0268-2868
Pierpaolo BruscoliniDepartamento de Física Teórica, Facultad de Ciencias, Universidad de Zaragoza, Zaragoza 50009, Spain.ORCID https://orcid.org/0000-0002-5833-8798

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polymerase cycling assembly (PCA) allows gene synthesis from the assembly of overlapping oligonucleotides. For optimal yield, the sets of overlapping fragments should present uniform hybridization temperatures and minimal spurious dimer formation, conditions that become particularly difficult to fulfill for short, GC-biased, or dimer-prone sequences. We present a new algorithm for designing overlapping oligonucleotides for PCA. Unlike heuristic-based methods, the approach maps the design onto a statistical physics model whose low-temperature solution can be obtained exactly, through a transfer-matrix formalism, when spurious heterodimer interactions are negligible; when they are not, it is complemented by a simulated-annealing repair step and, optionally, by codon redesign, generating high-quality, thermodynamically consistent oligonucleotide sets. We evaluated the method on over 10,000 sequences previously deemed unsuitable for synthesis, successfully recovering roughly 80% of them, and more than 91% if codon redesign is allowed. Experimental validation on a subset of 14 representative designs confirmed the absence of dimer formation, with all assemblies yielding clean bands in agarose gel electrophoresis. Our approach offers a robust and reliable solution for oligonucleotide design, particularly in challenging sequence contexts, and represents a valuable tool for synthetic biology and automated gene assembly workflows.

Identifiers

PMID42564310
PMCPMC13443015

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.